We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
49 result(s) found, displaying 21 to 30
-
Prescription medicine registrationActive ingredients: estradiol hemihydrate, progesterone.
-
Cancellation by sponsorRequested by Theramex Australia Pty Ltd
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Follitropin alfa
-
Prescription medicine decision summaryTGA decision: Ovaleap (follitropin alfa) is approved to treat anovulatory infertility in woman who are unresponsive to clomiphene citrate.
-
Prescription medicine registrationActive ingredients: follitropin alfa.
-
Cancellation by sponsorRequested by Theramex Australia Pty Ltd
-
Cancellation by sponsorRequested by Theramex Australia Pty Ltd
-
Cancellation by sponsorRequested by Theramex Australia Pty Ltd
-
Cancellation by sponsorRequested by Theramex Australia Pty Ltd
-
Cancellation by sponsorRequested by Theramex Australia Pty Ltd